REMINDER: Our user survey closes on Friday, please submit your responses here.
I agree MM, don't need our noses rubbing in it.
I do think it's time that the company made some kind of noise. There silence is deafening.
ssl - I've reported him as well to LSE and have just cancelled my subscription with LSE. They came out with crap that he's entitled to his speech. But when I said he's been faking details, they never replied. So decided they don't deserve my money.
I've also reported him to FUM and they passed details onto they brokers etc to look into his posting, That was ages ago and obviously they aren't going to do anything about it.
Guess this is the era of "fake news"
done 5151
TI - I've just looked and they don't mention any period in any previous RNS's. All they say is product launch in 2022 in the EU and other "fast track" areas which will accept the EU CE certificate...
yep a big week...but in the wrong direction.
Those results were very disappointing, hence the price drop.
thx for info...
ps, isnt it quiet with lb being filtered as no idea what the tnuc is saying....sorry swearing had a few to many glasses of wine lol
that was a large order at 1629 - what do people think it was a buy or sell.
Can't always tell with LSE, as i bought some ECR and LSE had it as a sell. I see ADFVN has it listed as unknown..
I just bought 102k shares and it's showing up as a sell.....shows you can't trust LSE much
I must be stupid (no comments), but do you have the link to the webcast as I can't find it.
Cash runway
The company continues to have sufficient cash resources beyond initial MED3000 launches in 2022 and expected US regulatory approval. The current runway does not include any revenues from commercial upfront milestones, royalties or other income generated from MED3000 sales."
This is my favourite part of the interims. With the upfront milestones and royalties, plus sales from EU/UK sales this should mean no more share dilutions.....but from past experience I won't hold my breath, but all looking good and solid.
YAWN.....and now filtered
Getting the interims tomorrow. Wonder if they'll give any updates regarding, well, everything. Not had any updates regarding TPR100 and CBD100 for a very long time. Plus surely we should of heard something about patents by now.
Personally I'm just expecting results and nothing sensational, as previously they just released figures.....but here's hoping..
I had hoped for a better reaction in the share price than this...oh well
Don't suspect we'll see much happening until we have a EU/UK partner and we have some more information on proposed timeline for the release to the the EU/UK market. If I remember rightly FUM said Q1 2022.....
https://www.lse.co.uk/rns/FUM/futura-announces-collaboration-with-labatec-pharma-s6taj1obeohlesw.html
Ticking along nicely, although being impatient would be nice for more...lol....
Hopefully we'll get some nice results on Wednesday as well. Although the two lots of upfront payments won't be reflected in the interims...
thanks for that, but if this is supposed to speed up results I'd hate to think how long it would take without the lab....
I'm confused (nothing unusual there lol)....but what is the point of having a lab if it doesn't get the results any quicker.
It's been weeks since we got the last assay results. I had assumed by having the lab (that every keeps saying is a good thing), would produce faster results. Maybe someone can enlighten me.
looks like I was wrong.......wonder when they will be issued. The last few years they've been issue late Aug to mid Sept
so, we should be getting interim results tomorrow.
Lets hope we get some updates on there other products, as we've heard nothing on them for a very long time.
Also would be nice to get told when MED will actually come to the market - but I'm not holding my breath on that, seeing as we've not got a deal with partner for the EU/UK - yet..
Far2L8 - totally agree with you.....don't know why people bother responding as it just gives me license to carry on....
here's hoping word is getting out there and people are seeing potential.
Also expecting share price to rise a little as half yearly results are due on the 14th Sept. As they say, buy on the rumour and sale on the fact.....